Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


21.05.2018

1 Am J Cardiol
1 Am J Epidemiol
1 Atherosclerosis
2 Biochem Biophys Res Commun
1 BMJ
1 Circulation
5 Diabet Med
1 Diabetes
5 Diabetes Care
8 Diabetes Obes Metab
2 Diabetologia
1 Eur J Endocrinol
2 J Clin Endocrinol Metab
2 J Diabetes Complications
1 J Pediatr
3 Lancet Diabetes Endocrinol
1 Med Care
1 Nutr Metab (Lond)
1 Ophthalmology
1 Pediatr Diabetes
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. PI SH, Rhee TM, Lee JM, Hwang D, et al
    Outcomes in Patients with Diabetes Mellitus According to Insulin Treatment After Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era.
    Am J Cardiol. 2018 Apr 18. pii: S0002-9149(18)30270.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  2. BRAVO MA, Anthopolos R, Kimbro RT, Miranda ML, et al
    Residential Racial Isolation and Spatial Patterning of Type 2 Diabetes Mellitus in Durham, North Carolina.
    Am J Epidemiol. 2018 May 14. pii: 4995328. doi: 10.1093.
    PubMed     Text format     Abstract available


    Atherosclerosis

  3. RAGGI P
    Angina severity, therapeutic choices and outcome in patients with diabetes mellitus.
    Atherosclerosis. 2018 May 3. pii: S0021-9150(18)30223.
    PubMed     Text format    


    Biochem Biophys Res Commun

  4. SASAKI M, Shinozaki S, Morinaga H, Kaneki M, et al
    iNOS inhibits hair regeneration in obese diabetic (ob/ob) mice.
    Biochem Biophys Res Commun. 2018 May 12. pii: S0006-291X(18)31126.
    PubMed     Text format     Abstract available

  5. MUKHERJEE S, Das S, Chattopadhyay D, Sarkar S, et al
    Attenuation of macrophage accumulation and polarisation in obese diabetic mice by a small molecule significantly improved insulin sensitivity.
    Biochem Biophys Res Commun. 2018 May 12. pii: S0006-291X(18)31123.
    PubMed     Text format     Abstract available


    BMJ

  6. DOBSON R, Whittaker R, Jiang Y, Maddison R, et al
    Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial.
    BMJ. 2018;361:k1959.
    PubMed     Text format     Abstract available


    Circulation

  7. VERMA S, Bhatt DL, Bain SC, Buse JB, et al
    Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.
    Circulation. 2018;137:2179-2183.
    PubMed     Text format    


    Diabet Med

  8. HVELPLUND KRISTIANSEN M, Banghoj AM, Laugesen E, Tarnow L, et al
    Arterial stiffness in people with Type 2 diabetes and obstructive sleep apnoea.
    Diabet Med. 2018 May 15. doi: 10.1111/dme.13666.
    PubMed     Text format     Abstract available

  9. HOLT RIG
    Psychosocial impact of diabetes.
    Diabet Med. 2018;35:675-676.
    PubMed     Text format    

  10. WIERZBICKI AS
    Further options for treating lipids in people with diabetes: targeting LDL-cholesterol and beyond.
    Diabet Med. 2018 May 15. doi: 10.1111/dme.13667.
    PubMed     Text format     Abstract available

  11. MACAULAY S, Munthali RJ, Dunger DB, Norris SA, et al
    The effects of gestational diabetes mellitus on fetal growth and neonatal birth measures in an African cohort.
    Diabet Med. 2018 May 15. doi: 10.1111/dme.13668.
    PubMed     Text format     Abstract available

  12. FIELD BCT, Nayar R, Kilvert A, Baxter M, et al
    A retrospective observational study of people with Type 1 diabetes with self-reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist intervention.
    Diabet Med. 2018 May 15. doi: 10.1111/dme.13670.
    PubMed     Text format     Abstract available


    Diabetes

  13. GREENBAUM CJ, Speake C, Krischer J, Buckner J, et al
    Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience.
    Diabetes. 2018 May 16. pii: db18-0065. doi: 10.2337/db18-0065.
    PubMed     Text format     Abstract available


    Diabetes Care

  14. SUISSA S
    Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?
    Diabetes Care. 2018;41:6-10.
    PubMed     Text format     Abstract available

  15. PAREEK M, Bhatt DL, Nielsen ML, Jagannathan R, et al
    Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study.
    Diabetes Care. 2018;41:171-177.
    PubMed     Text format     Abstract available

  16. NEUWAHL SJ, Honeycutt AA, Poehler DC, Shrestha SS, et al
    Diabetes-Attributable Nursing Home Costs for Each U.S. State.
    Diabetes Care. 2018 May 14. pii: dc17-2028. doi: 10.2337/dc17-2028.
    PubMed     Text format     Abstract available

  17. DESAI D, Mehta D, Mathias P, Menon G, et al
    Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis.
    Diabetes Care. 2018 May 17. pii: dc17-1379. doi: 10.2337/dc17-1379.
    PubMed     Text format     Abstract available

  18. BRIL F, Portillo-Sanchez P, Liu IC, Kalavalapalli S, et al
    Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.
    Diabetes Care. 2018;41:187-192.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  19. KAWAMORI R, Haneda M, Suzaki K, Cheng G, et al
    Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial.
    Diabetes Obes Metab. 2018 May 15. doi: 10.1111/dom.13352.
    PubMed     Text format     Abstract available

  20. HOME PD, Lam RLH, Carofano WL, Golm GT, et al
    Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: a randomized, open-label clinical trial.
    Diabetes Obes Metab. 2018 May 15. doi: 10.1111/dom.13354.
    PubMed     Text format     Abstract available

  21. SUZUKI R, Eiki JI, Moritoyo T, Furihata K, et al
    Effect of Short Term Treatment with Sitagliptin or Glibenclamide on Daily Glucose Fluctuation in Drug-naive Japanese Patients with Type 2 Diabetes Mellitus.
    Diabetes Obes Metab. 2018 May 17. doi: 10.1111/dom.13364.
    PubMed     Text format     Abstract available

  22. AHREN B, Atkin SL, Charpentier G, Warren ML, et al
    Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in SUSTAIN 1-5 trials.
    Diabetes Obes Metab. 2018 May 15. doi: 10.1111/dom.13353.
    PubMed     Text format     Abstract available

  23. SHIMADA A, Hanafusa T, Yasui A, Lee G, et al
    Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4-week, double-blind, randomized, placebo-controlled phase 2 trial.
    Diabetes Obes Metab. 2018 May 15. doi: 10.1111/dom.13351.
    PubMed     Text format     Abstract available

  24. ANDREADIS P, Karagiannis T, Malandris K, Avgerinos I, et al
    Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis.
    Diabetes Obes Metab. 2018 May 13. doi: 10.1111/dom.13361.
    PubMed     Text format     Abstract available

  25. BAILEY CJ
    European Medicines Agency: approval of new glucose-lowering medicines for type 2 diabetes.
    Diabetes Obes Metab. 2018 May 13. doi: 10.1111/dom.13360.
    PubMed     Text format     Abstract available

  26. HOLLANDER PA, Carofano WL, Lam RLH, Golm GT, et al
    Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: a randomized, open-label clinical trial.
    Diabetes Obes Metab. 2018 May 14. doi: 10.1111/dom.13363.
    PubMed     Text format     Abstract available


    Diabetologia

  27. HOUGHTON D, Hardy T, Stewart C, Errington L, et al
    Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes.
    Diabetologia. 2018 May 12. pii: 10.1007/s00125-018-4632.
    PubMed     Text format     Abstract available

  28. DUNN JT, Choudhary P, Teh MM, Macdonald I, et al
    The impact of hypoglycaemia awareness status on regional brain responses to acute hypoglycaemia in men with type 1 diabetes.
    Diabetologia. 2018 May 12. pii: 10.1007/s00125-018-4622.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  29. KNOP FK
    EJE PRIZE 2018: A gut feeling about glucagon.
    Eur J Endocrinol. 2018;178:R267-R280.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  30. ROKAMP KZ, Olsen NV, Faerch L, Kristensen PL, et al
    Impact of genetic polymorphism in the beta(2)-receptor gene on risk of severe hypoglycemia in patients with type 1 diabetes.
    J Clin Endocrinol Metab. 2018 May 10. pii: 4994586. doi: 10.1210/jc.2017-02739.
    PubMed     Text format     Abstract available

  31. HOLMES VA, Draffin CR, Patterson CC, Francis L, et al
    Postnatal Lifestyle Intervention For Overweight Women With Previous Gestational Diabetes: A Randomized Controlled Trial.
    J Clin Endocrinol Metab. 2018 May 11. pii: 4994591. doi: 10.1210/jc.2017-02654.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  32. MCCOY RG, Herrin J, Lipska KJ, Shah ND, et al
    Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes.
    J Diabetes Complications. 2018 Apr 24. pii: S1056-8727(18)30086.
    PubMed     Text format     Abstract available

  33. MOON S, Park JH, Yu JM, Choi MK, et al
    Association between diabetes mellitus and hearing impairment in American and Korean populations.
    J Diabetes Complications. 2018 Apr 20. pii: S1056-8727(17)31606.
    PubMed     Text format     Abstract available


    J Pediatr

  34. CUMMINGS LAM, Clarke A, Sochett E, Daneman D, et al
    Social Determinants of Health Are Associated with Markers of Renal Injury in Adolescents with Type 1 Diabetes.
    J Pediatr. 2018 May 8. pii: S0022-3476(18)30377.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol


  35. Correction to Lancet Diabetes Endocrinol 2018; published online May 4. http://dx.doi.org/10.1016/S2213-8587(18)30105-0.
    Lancet Diabetes Endocrinol. 2018 May 10. pii: S2213-8587(18)30151.
    PubMed     Text format    


  36. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies.
    Lancet Diabetes Endocrinol. 2018 May 8. pii: S2213-8587(18)30079.
    PubMed     Text format     Abstract available

  37. NORHAMMAR A
    Diabetes and cardiovascular mortality: the impact of sex.
    Lancet Diabetes Endocrinol. 2018 May 8. pii: S2213-8587(18)30111.
    PubMed     Text format    


    Med Care

  38. KIM DD, Arterburn DE, Sullivan SD, Basu A, et al
    Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes.
    Med Care. 2018 May 12. doi: 10.1097/MLR.0000000000000924.
    PubMed     Text format     Abstract available


    Nutr Metab (Lond)

  39. SOLTANIAN N, Janghorbani M
    A randomized trial of the effects of flaxseed to manage constipation, weight, glycemia, and lipids in constipated patients with type 2 diabetes.
    Nutr Metab (Lond). 2018;15:36.
    PubMed     Text format     Abstract available


    Ophthalmology

  40. REDDY RK, Pieramici DJ, Gune S, Ghanekar A, et al
    Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
    Ophthalmology. 2018 May 8. pii: S0161-6420(17)33607.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  41. PINTO CA, Stafford JM, Wang T, Shankar RR, et al
    Changes in Diabetes Medication Regimens and Glycemic Control in Adolescents and Young Adults with Youth Onset Type 2 Diabetes: the SEARCH for Diabetes in Youth Study.
    Pediatr Diabetes. 2018 May 15. doi: 10.1111/pedi.12691.
    PubMed     Text format     Abstract available


    PLoS One

  42. ROZENBERG K, Rosenzweig T
    Sarcopoterium spinosum extract improved insulin sensitivity in mice models of glucose intolerance and diabetes.
    PLoS One. 2018;13:e0196736.
    PubMed     Text format     Abstract available

  43. NWOSU BU, Zhang B, Ayyoub SS, Choi S, et al
    Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis.
    PLoS One. 2018;13:e0196912.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: